Related Experiment Video
Updated: Jan 25, 2026
Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
[Control of cardiovascular risk factors in patients after myocardial infarction]
Jan W Pęksa1, Piotr Jankowski1, Danuta Czarnecka1
1I Klinika Kardiologii i Elektrokardiologii Interwencyjnej Oraz Nadciśnienia Tętniczego, Uniwersytet Jagielloński w Krakowie, Kraków, Polska.
Insights
Cardiovascular disease prevention significantly lowers heart attack risk through lifestyle changes and medical management. Patients with high cardiovascular risk benefit from diet, exercise, smoking cessation, and controlled risk factors like cholesterol and blood pressure.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Cardiovascular diseases remain a leading cause of death globally, despite recent diagnostic and treatment advancements.
- Coronary heart disease incidence has decreased in Europe due to effective cardiovascular prevention strategies.
- Patients post-myocardial infarction represent a high-risk group requiring intensive management.
Purpose of the Study:
- To outline comprehensive strategies for managing patients at very high cardiovascular risk, particularly those post-myocardial infarction.
- To emphasize the importance of integrating lifestyle modifications with pharmacological interventions.
- To detail specific targets for risk factor control to improve patient outcomes.
Main Methods:
- Individual-level interventions focusing on lifestyle improvements: adopting a heart-healthy diet (low saturated fats, high whole grains, vegetables, fruits, fish), regular aerobic physical activity (150 min/week), and weight management.
- Pharmacological management of risk factors including dyslipidemia (LDL cholesterol <1.8 mmol/l or ≥50% reduction), hypertension (target BP 120-130/70-79 mmHg for 18-65 yrs, 130-139/70-79 mmHg for older adults), diabetes (HbA1c <7%), and smoking cessation support.
- Antiplatelet therapy, typically dual antiplatelet therapy for 12 months post-acute coronary syndrome.
Main Results:
- Implementation of these multifaceted strategies leads to significant improvements in patients' quality of life.
- These interventions demonstrably decrease mortality rates associated with cardiovascular diseases.
- Achieving targeted control of modifiable risk factors is crucial for long-term patient prognosis.
Conclusions:
- A comprehensive approach combining lifestyle changes and aggressive pharmacological risk factor management is essential for high-risk cardiovascular patients.
- Personalized interventions tailored to individual patient needs are key to successful cardiovascular disease prevention.
- Continued focus on evidence-based prevention strategies can further reduce the burden of cardiovascular morbidity and mortality.
Abstract:
Despite significant improvements in the diagnosis and treatment of cardiovascular diseases that have occurred in recent years, they remain the main cause of morbidity and mortality in the population. In many European countries, the incidence of coronary heart disease is currently 50% lower than it was in the early 1980s, which is the result of cardiovascular prevention. A special group of patients are people after myocardial infarction with very high cardiovascular risk. They should definitely implement activities at the individual level e. g. work on improving the unhealthy lifestyle and pharmacologically control other risk factors. A diet low in saturated fats should be recommended, i.e. mainly containing whole grains, vegetables, fruits and fish, recommend regular physical exercise: 150 min / week of moderate, aerobic physical activity, reducing the supply of calories in order to get rid of overweight or obesity. Help in quitting tobacco addiction should take place through the minimal nicotine intervention and, if necessary, pharmacological therapy. Another thing is the control of other risk factors, i. e. the appropriate treatment of dyslipidemia (the primary target is LDL cholesterol <1.8 mmol/l or reduction by ≥ 50%, if the initial concentration is between 1.8 and 3.5 mmol/l, treatment hypertension (target arterial pressure for most people aged 18-65 is in the range: 120-130/70-79 mmHg, if it is well tolerated, while for older people it is in the range: 130-139/70-79mmHg, if it is well tolerated), optimal diabetes therapy (target glycated hemoglobin <7%) and appropriate antiplatelet therapy (in most patients double antiplatelet therapy is recommended for 12 months after acute coronary syndrome). These activities lead to a significant improvement in quality of life and a decrease in mortality due to cardiovascular diseases.
Related Concept Videos
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
01:12Relative Risk
01:14Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
02:16Transcription Factors